1. Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events

   • Peter K. Schädlich
   • Josef Georg Brecht
   • Eduard Huppertz

   Original Research Article 22 September 2012 Pages: 955 - 973

   

2. Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation?

   • Akira Babazono
   • Motonobu Miyazaki
   • Alan L. Hillman

   Original Research Article 22 September 2012 Pages: 975 - 983

   

3. Economic Impact of Migraine and Other Episodic Headaches in France

   • André Pradalier
   • Jean-Paul Auray
   • Anne-François Gaudin

   Original Research Article 22 September 2012 Pages: 985 - 999

   

4. Comparisons of Hypertension-Related Costs from Multinational Clinical Studies

   • C. Daniel Mullins
   • Mirko Sikirica
   • Kasem S. Akhras

   Original Research Article 22 September 2012 Pages: 1001 - 1014

   

5. Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus

   • Frederick B. Dong
   • Stephen W. Sorensen
   • Michael M. Engelgau

   Original Research Article 22 September 2012 Pages: 1015 - 1027